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Background: Physicians commonly judge whether a myocardial
infarction (MI) is type 1 (thrombotic) vs type 2 (supply/demand
mismatch) based on clinical information. Little is known about the
accuracy of physicians’ clinical judgement in this regard. We aimed to
determine the accuracy of physicians’ judgement in the classification
of type 1 vs type 2 MI in perioperative and nonoperative settings.
Methods:We performed an online survey using cases from the Optical
Coherence Tomographic Imaging of Thrombus (OPTIMUS) Study,Received for publication April 29, 2020. Accepted July 13, 2020.
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Contexte : Les medecins determinent generalement s’ils sont en
presence d’un infarctus du myocarde (IM) de type 1 (thrombotique) ou
de type 2 (demande accrue ou apport reduit en oxygène) sur la base
des renseignements cliniques. On en sait cependant très peu au sujet
de la justesse du jugement clinique des medecins à cet egard. Nous
avons donc cherche à determiner si les medecins reussissent à dis-
tinguer correctement les IM de type 1 et de type 2 dans les contextes
perioperatoire et non operatoire.Myocardial infarction (MI) is one of the leading causes of
mortality worldwide.1,2 In the perioperative setting, MI is one
of the most common clinical complications after noncardiac
surgery.3,4 There is debate regarding the pathophysiology of
perioperative MI. Patients undergoing noncardiac surgery aresusceptible to sympathetic nervous system activation, tachy-
cardia, bleeding, hypertension, and hypotension, which can
lead to cardiac oxygen supply-demand mismatch. Surgery also
causes hypercoagulability and inflammation, which can trigger
platelet activation, plaque destabilization, erosion, or rupture,
leading to thrombus formation. These mechanisms fall within
different categories of the Universal Definition of MI, type 1
(thrombotic) or type 2 (supply-demand mismatch).5
In the perioperative and nonoperative setting, it is unclear
how accurate physicians are at determining whether a none
ST segment elevation MI (NSTEMI) is type 1 vs type 2
based only on clinical information. Physician judgement
about MI etiology often has implications for patient man-
agement and may influence whether physicians opt for a
conservative vs invasive treatment strategy.5This is an open access article under the CC BY-NC-ND license (http://
which investigated the prevalence of a culprit lesion thrombus based
on intracoronary optical coherence tomography (OCT) in patients
experiencing MI. Four MI cases, 2 perioperative and 2 nonoperative,
were selected randomly, stratified by etiology. Physicians were pro-
vided with the patient’s medical history, laboratory parameters, and
electrocardiograms. Physicians did not have access to intracoronary
OCT results. The primary outcome was the accuracy of physicians’
judgement of MI etiology, measured as raw agreement between phy-
sicians and intracoronary OCT findings. Fleiss’ kappa and Gwet’s AC1
were calculated to correct for chance.
Results: The response rate was 57% (308 of 536). Respondents were
62% male; median age was 45 years (standard deviation  11); 45%
had been in practice for > 15 years. Respondents’ overall accuracy for
MI etiology was 60% (95% confidence interval [CI] 57%-63%),
including 63% (95% CI 60%-68%) for nonoperative cases, and 56%
(95% CI 52%-60%) for perioperative cases. Overall chance-corrected
agreement was poor (kappa ¼ 0.05), consistent across specialties
and clinical scenarios.
Conclusions: Physician accuracy in determining MI etiology based on
clinical information is poor. Physicians should consider results from
other testing, such as invasive coronary angiography, when deter-
mining MI etiology.
Methodologie : Nous avons mene une enquête en ligne en utilisant les
cas de l’etude OPTIMUS (Optical Coherence Tomographic Imaging of
Thrombus), qui avait evalue la prevalence des lesions causant un
thrombus au moyen de la tomographie par coherence optique (TCO)
endocoronaire chez les patients subissant un IM. Nous avons choisi au
hasard quatre cas d’IM stratifies en fonction de leur cause : deux cas
en contexte perioperatoire et deux cas en contexte non operatoire. Les
medecins avaient accès aux antecedents medicaux, aux resultats des
analyses de laboratoire et aux electrocardiogrammes des patients,
mais pas aux resultats de la TCO endocoronaire. Le principal para-
mètre d’evaluation etait la justesse du jugement du medecin con-
cernant la cause de l’IM, mesuree en fonction de la concordance
approximative entre le jugement du medecin et les observations à la
TCO endocoronaire. Les coefficients de concordance kappa de Fleiss et
AC1 de Gwet ont servi à corriger pour le hasard.
Resultats : Le taux de reponse etait de 57 % (308 sur 536). Des
participants, 62 % etaient des hommes et 45 % exerçaient depuis plus
de 15 ans; l’âge median etait de 45 ans (ecart-type :  11). La jus-
tesse globale avec laquelle les repondants ont determine la cause des
IM etait de 60 % (intervalle de confiance [IC] à 95 % : 57-63 %) : 63 %
(IC à 95 % : 60-68 %) dans le cas des IM en contexte non operatoire et
56 % (IC à 95 % : 52-60 %) dans le cas des IM en contexte
perioperatoire. La concordance globale corrigee pour le hasard etait
faible (kappa ¼ 0,05) et demeurait constante, sans egard au domaine
de specialite ou au scenario clinique.
Conclusions : La justesse du jugement des medecins evaluant la
cause d’un IM en fonction des renseignements cliniques est faible. Les
medecins devraient envisager de recourir à des tests additionnels, y
compris la coronarographie invasive, avant de determiner la cause
d’un IM.
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graphic Imaging of Thrombus (OPTIMUS) Study to deter-
mine the prevalence of a culprit lesion thrombus in patients
experiencing a perioperative NSTEMI, compared with a
matched cohort of patients experiencing a nonoperative
NSTEMI, using intracoronary optical coherence tomography
(OCT).6 OCT is an accurate intravascular imaging technique
for the detection of thrombus, and thus classification of MI
etiology.7-9 The main objective of this current study was to
determine the accuracy of physicians’ judgement in the classi-
fication of NSTEMI etiology (ie, type 1 vs type 2) in patients
diagnosed with NSTEMI in both perioperative and nonoper-
ative scenarios, using cases from the OPTIMUS Study.Materials and Methods
Study design
We undertook a cross-sectional online survey study that
evaluated physician accuracy in judgement of MI etiology
using real cases from the OPTIMUS Study database.
Participants
From July 2017 to January 2018, we recruited anaes-
thesiologists, noninvasive and invasive cardiologists, and
general internists (ie, the specialists most commonly involved
with perioperative MIs) from 7 centres in Brazil, Canada, and
Italy (Supplemental Table S1). We excluded investigators
involved in the design of the survey, physicians originallyinvolved in the cases, physicians whose scope of practice did
not include management of MI, and physicians on leave (ie,
out-of-office message for more than 6 months). Representa-
tives of each specialty were contacted by e-mail and invited to
participate in the survey. Individuals were sent electronic re-
minders every 2 weeks. To maximize the response rate, we
used a short questionnaire, emphasized the relevance of the
topic, offered to provide the survey results, and assured
confidentiality.10,11 Local leaders directly contacted non-
respondents to encourage participation.
Data source
We developed cases for the survey from the OPTIMUS
Study. The OPTIMUS Study was a prospective cohort
study of 60 patients (30 patients who had a perioperative
MI, and 30 patients who had a nonoperative MI) that
used OCT imaging to determine the presence of intra-
coronary thrombus. Full methods of the OPTIMUS Study
are published elsewhere.6 In brief, eligible patients were
aged > 18 years, experienced an MI after noncardiac
surgery or nonoperative MI that fulfilled the Universal
Definition of MI,5 and underwent cardiac angiography
within 3 days of the event. For each included perioperative
MI patient, a nonoperative MI patient was matched based
on gender, age, and ECG ischemic changes. Patients were
excluded if they had an ST segment elevation myocardial
infarction, cardiac revascularization in the prior 6 months,









N = 56 (9.5%)
15 Other specialty practice
13 Local leaders
11 Not active/on leave > 6 months
8 Outpatient practice only
6 Research /administrative only
3 Imaging/procedure practice only
Figure 1. Participant flowchart.
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OCT imaging. OCT images were evaluated by a core labo-
ratory (Cardiovascular Imaging Core Laboratory, Case
Western Reserve University, Cleveland, OH). Two indepen-
dent interventional cardiologists, blinded to whether patients
had suffered a perioperative or nonoperative MI, reviewed all
images and decided on the presence or absence of intra-
coronary thrombus.
We randomly selected 4 cases from the OPTIMUS Study
that underwent successful OCT imaging and for which we
had all the clinical progress notes and consults, ECGs, and
troponin results. We divided the OPTIMUS cases into 4
groups according to both clinical scenario (perioperative and
nonoperative MI) and the final MI etiology based on OCT
results (type 1 and type 2 MI). We defined type 1 MI cases as
the presence of thrombus at the culprit lesion based on OCT,
and type 2 MI cases as the absence of thrombus or plaque
rupture in the culprit artery based on OCT. Then, we
randomly selected one case from each group. We prespecified
that in the event the selected case did not have complete
clinical information, serial troponin measurements, or an
ECG, we would randomly select another case in that specific
subgroup. All 4 cases selected were considered complete. Case
details are provided in the Supplemental Appendix S4.
Primary outcome
The primary outcome was the accuracy of physicians’
judgement of MI etiology (type 1 vs type 2) based on the
clinical information without knowledge of the OCT re-
sults. The OCT findings were used as the “gold
standard.“
Case assessment
Invited physicians received a login linked to a unique
token to access the survey with full documentation for all
cases. Each token could be used only once. We used
LimeSurvey (https://surveys.mcmaster.ca/limesurvey), which
is a free-access Internet-based survey platform. Each physi-
cian was invited to evaluate the cases, which were presentedin a random order unique to each token. Respondents were
blinded to cardiac angiography and OCT results. For each
case, physicians were provided with the original consulting
physician’s progress and consultation notes, ECG images,
and laboratory results, including troponins, compiled until
the day of cardiac angiography. Physicians were invited to
indicate whether they believed the case was a type 1 or type
2 MI. They were also asked to provide data on their de-
mographics, including their clinical practice (eg, years of
practice, specialty, practice location, and percentage of
practice devoted to clinical care). Details on the consent form
and questionnaire are presented in the Supplemental
Appendix S3.
Survey development and testing
The questionnaire was developed by a multidisciplinary
group of physicians who planned, discussed, and built the
final questionnaire based on the results of survey testing.
Feedback was collected to evaluate the content and the time
needed to complete the questionnaire. A total of 14 of 17
invited physicians (including anaesthesiologists, cardiologists,
and internists) participated in the survey development. All
survey questions were presented, and the group was asked to
judge the adequacy of documentation provided for the sample
cases. Based on the information obtained through the devel-
opment process, we expected that respondents would be able
to complete a case within 5 minutes.
Statistical analysis
We report number of physicians invited, reasons for
exclusion, and response rate (number of respondents of the
total invited who were eligible). Respondents’ characteristics
are presented as proportions for categorical variables, mean
and standard deviation (SD) for normally distributed
continuous variables, and median and interquartile ranges for
nonenormally distributed variables. We report overall clinical
judgement accuracy as the proportion of physicians’ answers
that were concordant with OCT findings, and its 95% con-
fidence interval (CI). A priori, we specified that we would
Table 1. Participant characteristics
Respondent profile Respondents (N ¼ 308)
Male 190 (62)




Interventional cardiology 13 (4)
Internal medicine 107 (35)
Years practicing specialty
< 5 51 (17)
5-15 117 (38)
> 15 140 (45)









> 30 28 (9)





> 30 74 (24)
Time devoted to clinical practice, %
< 20 41 (13)
20-50 49 (16)
> 50 218 (71)
Values are n (%) or mean  standard deviation.
MI, myocardial infarction.
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Volume 2 2020report accuracy according to clinical scenarios (ie, periopera-
tive and nonoperative), and the following physician charac-
teristics: specialty (anaesthesia; internal medicine; cardiology);
years of clinical work after completing training (< 5; 5-15; >
15); and proportion of time dedicated to clinical practice (<
20%, 21%-50%, > 50%). To estimate overall accuracy and
the accuracy by subgroup, and the corresponding 95% CI, we
used log-binomial generalized estimating equations to account
for repeated measures per respondent. We report the accuracy
by single clinical scenario with 95% CI using generalized
linear models based on log-binomial distribution. We also
explored whether physician and scenario characteristics inde-
pendently predicted the accuracy of clinical judgement in
univariate and multivariable generalized estimating equation
models. Variables included in the model defined a priori were
the following: clinical scenario, clinical specialty, years of
clinical experience, and time dedicated to clinical practice. We
performed a post hoc multivariate analysis including the
number of MI cases per year managed by physicians in the last
12 months. Additionally, we reported clinical judgement ac-
curacy by type 1 and type 2 MI.
Fleiss’ kappa statistic was calculated for overall chance-
correct agreement between physicians and OCT findings on
the determination of MI etiology.12 Fleiss’ kappa is the chance-
correct agreement measure for multiple raters, where values
close to zero indicate agreement no better than by chance, and
values close to one are considered to reflect perfect agreement.
Fleiss’ kappa values were interpreted as follows: values greaterthan 0.75dstrong agreement; values between 0.40 and
0.75dfair to good agreement; values < 0.40d poor agree-
ment; and values< 0dno agreement.13 We determined kappa
by specialty and by clinical scenario (perioperative and
nonoperative). We report kappa value and 95% CI.
To overcome the kappa paradox, which occurs when high
raters’ agreement can be translated into misleading smaller
kappa values, we also determined Gwet’s AC1 analysis.14-16
We interpreted Gwet’s AC1 analysis using the same param-
eters as those used for Fleiss’ kappa.15
Analyses were completed using SPSS version 17.0 (IBM,
Armonk, NY) and STATA version 12 (StataCorp, College
Station, TX). We considered a 2-tailed P-value < 0.05 sta-
tistically significant.
Ethical considerations
The study protocol was approved by the Hamilton Inte-
grated Research Ethics Board, and all participants signed an
electronic informed consent form. All patient information was
kept confidential, and all patient identifiers were removed
from the source documents provided to physicians. Physicians
were not linked to their responses. All information was ob-
tained using a secure Web-based system, and stored in
anonymous, aggregate form.Results
Survey respondent characteristics
Among 592 potential participants, 56 (9.5%) were not
eligible. Figure 1 shows reasons for exclusion. The response
rate was 308 (57%). The proportions of respondents by
country and by clinical specialty are presented in
Supplemental Table S2. There were 1144 assessed cases, with
an average of 3.7 cases (minimum 1; maximum 4) per
respondent. Most physicians completed all cases (88%). Re-
spondents were 62% male, and had a median age of 45 years
(SD  11). With respect to specialty, 44% were anaesthesi-
ologists, 35% were internists, and 21% were cardiologists.
Respondent characteristics are presented in Table 1.
Accuracy of clinical assessment of MI etiology
Figure 2 presents the distribution of physicians’ responses
by OCT-based MI etiology and physicians’ level of confidence
in their judgement for each case. Overall accuracy of clinical
judgement (ie, agreement between physicians and OCT)
across 1144 cases was 60% (95% CI 57%-63%). Accuracy
was 63% (95% CI 59.5%-67.5%) for nonoperative MI and
56% (95% CI 52%-60%) for perioperative MI. The majority
of respondents were confident about their assessments.
Table 2 presents overall accuracy, and accuracy according to
MI type by training level and specialty. Overall MI accuracy
was similar according to physician experience. Details are
provided in the Supplemental Tables S3 and S4. In the uni-
variate analysis to predict physicians’ accuracy, only clinical
setting (perioperative vs nonoperative) was statistically signif-
icant (risk ratio 0.88; 95% CI 0.80-0.97; P ¼ 0.013]. None
of the physician characteristics (eg, clinical specialty, years of
clinical experience, and time dedicated to clinical practice)








































































Intracoronary Optical Coherence Tomography results
Figure 2. Distribution of (A) physicians’ responses and (B) level of confidence by case (%).
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including the number of MIs managed by physicians in the
last 12 months did not yield different results. Details of the
multivariate analysis are presented in the Supplemental Tables
S5 and S6.
Fleiss’ kappa statistic was 0.05 for overall chance-correct
agreement between physicians and OCT findings on the deter-
mination ofMI etiology. Fleiss’ kappa agreementwas consistently
poor by clinical specialty, and by clinical scenario. Gwet’s AC1
values confirmed low chance-adjusted agreement (Table 3).
Discussion
This multicenter international survey demonstrates poor
physician overall accuracy (60%) for judging type 1 vs type 2MI based on clinical data compared to OCT. Although
physician accuracy in determining MI etiology was lower in
the setting of perioperative MI compared with nonoperative
MI (risk ratio 0.88; 95% CI 0.80-0.97), accuracy for
nonoperative MI was also poor (accuracy 63%). Our study
demonstrates that accuracy in classifying type 2 MI is lower
than that for type 1 MI (51% vs 69%; P < 0.001). Overall
chance-correct agreement between physicians and OCT
findings on the determination of MI etiology (type 1 vs 2) was
poor (kappa ¼ 0.05; Gwet’s AC1 ¼ 0.11), consistent across
the nonoperative and perioperative settings and the various
clinical specialties. Despite the low accuracy and agreement
beyond chance, most physicians were confident in their
judgement.
Table 2. Accuracy of physicians’ judgement compared to intracoronary optical coherence tomography
Variables Overall accuracy Type I MI accuracy Type II MI accuracy P
Overall cases 60 (57-63) 69 (65-73) 51 (47-55) < 0.001
By clinical scenario
Nonoperative 63 (60-68) 77 (73-82) 49 (43-55) < 0.001
Perioperative 56 (52-60) 60 (54-66) 52 (46-58) 0.057
By specialty
Anaesthesia 63 (58-69) 84 (76-91) 42 (32-52) < 0.001
Cardiology 59 (55-63) 61 (55-67) 56 (50-62) 0.308
Internal medicine 60 (55-65) 73 (67-79) 47 (40-54) <0.001
By years practicing specialty
< 5 58 (51-66) 63 (53-73) 53 (43-63) 0.161
5-15 60 (56-65) 75 (69-81) 45 (39-52) < 0.001
> 15 60 (56-65) 66 (60 -72) 54 (48-61) 0.010
By time devoted to clinical practice, %
< 20 60 (51-70) 58 (47-65) 62 (51-73) 0.501
20-50 61 (55-68) 75 (66-84) 47 (37-58) < 0.001
> 50 60 (56-65) 69 (65-74) 49 (44-54) < 0.001
Values are % (95% confidence interval), unless otherwise indicated.
MI, myocardial infarction.
Table 3. Fleiss‘ kappa (k) and Gwet’s AC1 (first order agreement
coefficient) agreement
Group k (95% CI) Gwet’s AC1 (95% CI)
All 0.05 (e0.05, 0.16) 0.11 (e0.24, 0.46)
Specialty
General cardiology 0.11 (e0.18, 0.39) 0.37 (e0.43, 1.00)
Interventional cardiology 0.01 (e0.12, 0.13) 0.13 (e0.31, 0.57)
Internal medicine 0.05 (e0.05, 0.15) 0.16 (e0.26, 0.59)
Anaesthesia 0.04 (e0.05, 0.12) 0.04 (e0.07, 0.14)
Clinical setting
Perioperative cases 0.01 (0.01, 0.02) 0.02 (e0.47, 0.52)




These findings demonstrate that physicians were limited in
their ability to predict beyond chance the underlying etiology
of NSTEMI based on patients’ clinical history, ECGs, and
troponin levels. Indeed, studies have shown that presence of
ischemic features (eg, ischemic symptoms, ischemic ECG
findings), and even troponin levels, is not predictive of
NSTEMI etiology.6
During the perioperative period, patients are exposed to
sympathetic activation that can trigger hypertension, tachy-
cardia, hyper-catabolism, and subsequent increase in cardiac
demand. Moreover, surgery is associated with bleeding, hy-
potension, and anemia, resulting in a supply and demand
imbalance.5 However, surgery also leads to hypercoagulability,
inflammation, and endothelial dysfunction, predisposing pa-
tients to thrombotic events. Several studies have demonstrated
the occurrence of type 1 MI, in 26% to 50% of patients with
perioperative MI.17-20 Yet, some of these studies are limited
by the use of inadequate methods to detect intracoronary
thrombus. The OPTIMUS Study used OCT and identified
thrombus at the culprit lesion in 13% of patients who have
experienced a perioperative MI as compared to 67% of those
who experienced a nonoperative MI.6 Physicians should take
into account prevalence of MI etiology in different clinical
settings to guide diagnostic approachs and medical treatments.
However, our study demonstrated that even among specialists
from tertiary care academic hospitals, a significant proportion
of patients suffering an MI were incorrectly classified without
information from an invasive coronary assessment.
A physician’s belief about whether an MI is type 1 vs 2
often has important therapeutic implications.21 If an MI is
thought to be type 1, the patient is more likely to receive dual
antiplatelet therapy and anticoagulation. Conversely, if an MI
is deemed to be type 2, the patient is more likely to receive
general treatment for anemia, hypotension, or the triggers
believed to be contributing to the ischemia process. In the
perioperative setting in particular, mostly as a result of con-
cerns for bleeding, patients with myocardial ischemia are
discharged from the hospital with limited cardiovascular sec-
ondary prevention treatment.22 Moreover, if a physicianassumes that a perioperative MI has occurred as a result of
supply-demand mismatch, patients may not be advanced for
further risk stratification (angiography and possible detection
of plaques requiring treatment).23
The Coronary CT Angiography to Predict Vascular
Events in Noncardiac Surgery Patients Cohort Evaluation
(Coronary CTA -VISION) study demonstrated that among
patients experiencing a perioperative MI, 72% had > 50%
coronary obstructive disease, and only 4% had normal
coronaries on computed tomographic angiography imag-
ing.24 A perioperative MI, regardless of whether it was type
1 or type 2, might be an opportunity to identify at-risk
patients with asymptomatic coronary artery disease and
offer medications with evidence for secondary cardiovascular
prevention, such as aspirin, statins, and angiotensin-
converting enzyme inhibitors. Recently, the Management
of Myocardial Injury After Noncardiac Surgery (MANAGE)
trial25,26 demonstrated that an intermediate-dose anti-
coagulation with dabigatran after a perioperative myocardial
injury (including type 1 and type 2 MI) prevented major
cardiovascular outcomes without increasing major bleedings
at a mean of 16 months of follow-up.
Accuracy of diagnosing type 1 MI, compared with type 2,
was significantly higher. These results suggest that physicians
should be even more careful when making the diagnosis of type
2MI. Physicians should not underestimate the impact of type 2
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perioperative settings. A recent systematic review and meta-
analyses has shown that among 25,872 patients, type 2 MI
patients had almost 3 times higher inpatient, 30-day, and 1-year
mortality, compared to those with type 1 MI. Operative stress
was the most common trigger of type 2 MI. Patients labeled as
type 2 MI were less likely to be referred to cardiac angiography,
compared with those with type 1 MI.27
Strengths and limitations
To our knowledge, this is the first study assessing the ac-
curacy of physician judgement of MI etiology in nonoperative
and perioperative settings. The strength of this study is the use
of real cases and the ability to compare physicians’ judgements
based on clinical information with OCT results. Physicians
were exposed to scenarios similar to those to which they are
exposed in daily clinical practice, where they commonly make
decisions on MI etiology and determine next steps in inves-
tigation and treatment. This is a multicentre study, in 7 in-
stitutions, with a reasonable response rate, and most
physicians completed all survey cases. We randomized the
order of the cases to keep response rates similar across all cases.
This study has limitations. To minimize the length of the
survey and increase the response rate, only 4 cases were
included. It is possible that cases presented may not be repre-
sentative of the variety of patients seen in practice, causing a
measurement effect; however, we selected random cases from
the OPTIMUS Study. Also, in order to include perioperative
and nonoperative settings, and type 1 and 2 etiologies, the case
prevalence in our sample (50% and 50%)was different from the
actual prevalence of type 1 vs type 2 MI in the perioperative
setting. Some physicians believe that type 2 MI is more com-
mon than type 1 MI after noncardiac surgery.28,29 Physicians
were not aware of the stratification, but given the low number of
cases and the purpose of the survey, they may have guessed the
even distribution of cases in the survey across settings and eti-
ologies. This approach would have given them a 50% proba-
bility of guessing the etiology by chance, which is close to the
accuracy we eventually found. The reported confidence in their
responses, however, is a signal that they were not simply
guessing, but rather based their responses on a believed
knowledge. A substantial proportion of the physicians had not
managed a considerable number of MIs in the year preceding
the survey. However, when our results were restricted to just
cardiologists, or to physicians who had managed more than 30
MIs in the preceding year, the overall accuracy of physicians’
judgements compared to OCT results did not improve
compared to the overall cohort.
A nonresponse effect could be an issue; however, this study
had a higher response rate than many survey studies. Although
OCT is arguably the best objective assessment of the MI eti-
ology, it is not 100% accurate. Thrombus could have been
dissolved already in patients classified as having had a type 2MI;
in the OPTIMUS study, the mean number of days from MI
diagnosis to OCT was 1.9 (SD 1.1) days in the perioperative
MI group and 1.5 (SD  0.7) days in the nonoperative MI
group. Some readers may believe that the Universal Definition
of MI angiography criteria for type 1 MI (ie, identification of a
coronary artery thrombus) is too restrictive and should be
expanded to include identification of plaque rupture. Althoughthe definition of type 1 MI used in this study was identification
of coronary artery thrombus, none of the cases of type 2MI used
in this survey had evidence of plaque rupture.
Finally, we measured the chance-corrected agreement
based on Fleiss’ kappa that could underestimate the agreement
when there is a high rate of agreement in one specific category.
However, Gwet’s AC1 should be a more stable measure of
agreement, as it is less affected by prevalence and marginal
probability.16 Our survey demonstrated similar results with
the 2 measures, as expected when the prevalence of categories
(type 1 and 2 MI in our case) was 0.5.Conclusions
Physicians’ capacity to accurately determine type 1 vs type 2
MI based on clinical information is poor, consistent across
different specialties, for both perioperative and nonoperative
MI. Physicians should take this information into account when
making treatment decisions based upon clinical assessment of
type 1 vs 2MI. There is a need for additional strategies to better
define MI etiology and guide clinical management.Funding Sources
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